HITI
High Tide Inc
NASDAQ · Pharmaceuticals
$2.35
+0.08 (+3.52%)
Open$2.27
Previous Close$2.27
Day High$2.38
Day Low$2.27
52W High$37.89
52W Low$28.31
Volume—
Avg Volume204.6K
Market Cap273.18M
P/E Ratio16.44
EPS$2.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,551.5% upside
Current
$2.35
$2.35
Target
$38.81
$38.81
$30.55
$38.81 avg
$50.01
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 121.78M | 117.29M | 114.78M |
| Net Income | 15.16M | 15.94M | 14.39M |
| Profit Margin | 12.5% | 13.6% | 12.5% |
| EBITDA | 21.06M | 20.19M | 19.55M |
| Free Cash Flow | 15.93M | 10.06M | 12.39M |
| Rev Growth | +0.5% | +17.8% | -7.5% |
| Debt/Equity | 1.38 | 1.32 | 1.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |